Roy Eldor
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Surgery top 5%
- Pancreatic function and diabetes
Papers in
-
- Diabetes Management and Research 23
- Diabetes Treatment and Management 17
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Surgery 15
- Pancreatic function and diabetes 11
- Co-authors
- Muhammad Abdul‐Ghani (6 shared papers)Ralph A. DeFronzo (4 shared papers)Itamar Raz (15 shared papers)Giuseppe Daniele (6 shared papers)Devjit Tripathy (4 shared papers)Juan Xiong (4 shared papers)Aurora Merovci (4 shared papers)Luke Norton (4 shared papers)
- Journals
- Diabetes/Metabolism Research and Reviews (9 papers)Diabetes Obesity and Metabolism (8 papers)Diabetes Care (7 papers)Diabetes (5 papers)Diabetes Research and Clinical Practice (4 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Roy Eldor
70 papers receiving 2.9k citations
Roy Eldor's Hit Papers
Peers
Comparison fields: 5 of 111
- Endocrinology, Diabetes and Metabolism 1.6k
- Surgery 843
- Pharmaceutical Science 88
- Physiology 331
- Genetics 360
Countries citing papers authored by Roy Eldor
This map shows the geographic impact of Roy Eldor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Eldor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Eldor more than expected).
Fields of papers citing papers by Roy Eldor
This network shows the impact of papers produced by Roy Eldor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Eldor. The network helps show where Roy Eldor may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Eldor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production Hit paper breakdown → | 2014 | 657 |
| 2 | 2013 | 237 | |
| 3 | 2006 | 219 | |
| 4 | 2004 | 171 | |
| 5 | 2016 | 169 | |
| 6 | 2017 | 135 | |
| 7 | 2017 | 123 | |
| 8 | 2004 | 102 | |
| 9 | 2013 | 100 | |
| 10 | 2006 | 87 | |
| 11 | 2011 | 84 | |
| 12 | 2013 | 82 | |
| 13 | 2013 | 63 | |
| 14 | 2020 | 51 | |
| 15 | 2009 | 50 | |
| 16 | 2017 | 47 | |
| 17 | 2005 | 40 | |
| 18 | 2006 | 35 | |
| 19 | 2021 | 31 | |
| 20 | 2009 | 30 |
About Roy Eldor
Roy Eldor is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Physiology, Molecular Biology and Genetics, having authored 72 papers that have together received 3.0k indexed citations. Recurring topics across this work include Diabetes Management and Research (23 papers), Diabetes Treatment and Management (17 papers), Pancreatic function and diabetes (11 papers), Metabolism, Diabetes, and Cancer (9 papers), Diabetes and associated disorders (8 papers), Adipose Tissue and Metabolism (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Surgery (843 citations), Pharmaceutical Science (88 citations), Physiology (331 citations) and Genetics (360 citations). Roy Eldor has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Muhammad Abdul‐Ghani, Ralph A. DeFronzo, Itamar Raz, Giuseppe Daniele, Devjit Tripathy, Juan Xiong, Aurora Merovci, Luke Norton, Carolina Solis‐Herrera and Teresa Vanessa Fiorentino. Their work appears in journals such as Diabetes/Metabolism Research and Reviews, Diabetes Obesity and Metabolism, Diabetes Care, Diabetes and Diabetes Research and Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.